Impact of the Duration of Diabetes Mellitus on the Outcome of Metastatic Pancreatic Cancer Treated with Gemcitabine: A Retrospective Study

OBJECTIVE: To assess the impact of the duration of diabetes mellitus (DM) on the outcomes of pancreatic cancer patients undergoing chemotherapy. METHODS: We reviewed the medical records of patients with metastatic pancreatic cancer who received gemcitabine monotherapy as the standard therapy before...

Descripción completa

Detalles Bibliográficos
Autores principales: Iizumi, Sakura, Kuchiba, Aya, Okusaka, Takuji, Ikeda, Masafumi, Sakamoto, Yasunari, Kondo, Shunsuke, Morizane, Chigusa, Ueno, Hideki, Osame, Keiichiro, Mitsunaga, Shuichi, Ohno, Izumi, Imaoka, Hiroshi, Hashimoto, Yusuke, Takahashi, Hideaki, Sasaki, Mitsuhito, Ohashi, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761348/
https://www.ncbi.nlm.nih.gov/pubmed/31178491
http://dx.doi.org/10.2169/internalmedicine.2539-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761348/
https://www.ncbi.nlm.nih.gov/pubmed/31178491
http://dx.doi.org/10.2169/internalmedicine.2539-18

Ejemplares similares